The Brain Tumor Funders' Collaborative

 

2018 FUNDING OPPORTUNITY: IMMUNOTHERAPY FOR PRIMARY HUMAN BRAIN TUMORS

The BTFC has selected 4 teams as BTFC collaborative grant award recipients. We are in the final stages of negotiation and plan to announce the awardees soon. Thank you.


Posted 2018-03-15
The Brain Tumor Funders’ Collaborative invites responses to its current funding initiative focused on understanding the complex dynamics among the constituents comprising the human neuro-immune system, the heterogeneity of the primary brain tumor, and the brain environment.  The BTFC is requesting proposals on the role of the neuro-immune system in the origin and progression of the immune responses in primary human brain tumors with the hope of developing immunotherapies for treatment of these tumors in patients. The initial response to the RFP requires pre-proposals describing studies on the complex roles of immune responses in the context of primary brain tumors in pediatric and/or adult human patients. The deadline to apply is May 11, 2018 no later than 17:00 CDT (22:00 UTC).